Documents

Ideas Discussions Technicals Forecast Seasonals Options

Vor Biopharma Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Vor Biopharma Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Data partner

Description

Reported date

Form

2025

Citi's Biopharma Back to School Conference

Sep 02, 2025

Transcript

Q2 2025

Aug 12, 2025

Quarterly report10-Q

Q1 2025

May 14, 2025

Quarterly report10-Q

Oppenheimer 35th Annual Healthcare Life Sciences Conference 2025

Feb 12, 2025

Transcript

2024

Q4 2024

Mar 19, 2025

Earnings release8-K

Annual report10-K

Status Update

Dec 09, 2024

Slides

Press release

Q3 2024

Nov 07, 2024

Earnings release8-K

Quarterly report10-Q

Study Update

Sep 05, 2024

Press release

Slides

Q2 2024

Aug 07, 2024

Quarterly report10-Q

Q1 2024

May 09, 2024

Quarterly report10-Q

Earnings release8-K

2023

Q4 2023

Mar 20, 2024

Earnings release8-K

Annual report10-K

Q3 2023

Nov 07, 2023

Quarterly report10-Q

Earnings release8-K

Q2 2023

Aug 10, 2023

Quarterly report10-Q

Earnings release8-K

Q1 2023

May 11, 2023

Quarterly report10-Q

Earnings release8-K

2022

Q4 2022

Mar 23, 2023

Slides

Annual report10-K

Study Result

Dec 07, 2022

Press release

Q3 2022

Nov 10, 2022

Quarterly report10-Q

Earnings release8-K

Q2 2022

Aug 11, 2022

Quarterly report10-Q

Earnings release8-K

Q1 2022

May 12, 2022

Quarterly report10-Q

Earnings release8-K

2021

Q4 2021

Mar 14, 2022

Earnings release8-K

Annual report10-K

Q3 2021

Nov 10, 2021

Quarterly report10-Q

Earnings release8-K

Q2 2021

Aug 09, 2021

Quarterly report10-Q

Earnings release8-K

Q1 2021

May 06, 2021

Quarterly report10-Q

Earnings release8-K

2020

Q4 2020

Mar 25, 2021

Annual report10-K